p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation

被引:0
|
作者
E V Broude
M E Swift
C Vivo
B-D Chang
B M Davis
S Kalurupalle
M V Blagosklonny
I B Roninson
机构
[1] Cancer Center,Department of Molecular Genetics
[2] Ordway Research Institute,undefined
[3] University of Illinois at Chicago,undefined
来源
Oncogene | 2007年 / 26卷
关键词
p21; Rb; p27; damage response;
D O I
暂无
中图分类号
学科分类号
摘要
Damage-induced G1 checkpoint in mammalian cells involves upregulation of p53, which activates transcription of p21Waf1 (CDKN1A). Inhibition of cyclin-dependent kinase (CDK)2 and CDK4/6 by p21 leads to dephosphorylation and activation of Rb. We now show that ectopic p21 expression in human HT1080 fibrosarcoma cells causes not only dephosphorylation but also depletion of Rb; this effect was p53-independent and susceptible to a proteasome inhibitor. CDK inhibitor p27 (CDKN1B) also caused Rb dephosphorylation and depletion, but another CDK inhibitor p16 (CDKN2A) induced only dephosphorylation but not depletion of Rb. Rb depletion was observed in both HT1080 and HCT116 colon carcinoma cells, where p21 was induced by DNA-damaging agents. Rb depletion after DNA damage did not occur in the absence of p21, and it was reduced when p21 induction was inhibited by p21-targeting short hairpin RNA or by a transdominant inhibitor of p53. These results indicate that p21 both activates Rb through dephosphorylation and inactivates it through degradation, suggesting negative feedback regulation of damage-induced cell-cycle checkpoint arrest.
引用
收藏
页码:6954 / 6958
页数:4
相关论文
共 50 条
  • [1] p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
    Broude, E. V.
    Swift, M. E.
    Vivo, C.
    Chang, B-D
    Davis, B. M.
    Kalurupalle, S.
    Blagosklonny, M. V.
    Roninson, I. B.
    [J]. ONCOGENE, 2007, 26 (48) : 6954 - 6958
  • [2] p21Waf1/Cip1/Sdi1 mediates shear stress-dependent antiapoptotic function
    Mattiussi, S
    Turrini, P
    Testolin, L
    Martelli, F
    Zaccagnini, G
    Mangoni, A
    Barlucchi, LM
    Antonini, A
    Illi, B
    Cirielli, C
    Padron, J
    Nicolò, C
    Testi, R
    Osculati, F
    Biglioli, P
    Capogrossi, MC
    Gaetano, C
    [J]. CARDIOVASCULAR RESEARCH, 2004, 61 (04) : 693 - 704
  • [3] Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress
    Karin Butz
    Caroline Geisen
    Angela Ullmann
    Hanswalter Zentgraf
    Felix Hoppe-Seyler
    [J]. Oncogene, 1998, 17 : 781 - 787
  • [4] Not Just a CDK Inhibitor: Regulation of Transcription by p21WAF1/CIP1/SDI1
    Perkins, Neil D.
    [J]. CELL CYCLE, 2002, 1 (01) : 39 - 41
  • [5] Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress
    Butz, K
    Geisen, C
    Ullmann, A
    Zentgraf, H
    Hoppe-Seyler, F
    [J]. ONCOGENE, 1998, 17 (06) : 781 - 787
  • [6] p21WAF1/Cip1/Sdi1 knockout mice respond to doxorubicin with reduced cardiotoxicity
    Terrand, Jerome
    Xu, Beibei
    Morrissy, Steve
    Dinh, Thai Nho
    Williams, Stuart
    Chen, Qin M.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 257 (01) : 102 - 110
  • [7] Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1
    Wang, F
    Yoshida, I
    Takamatsu, M
    Ishido, S
    Fujita, T
    Oka, K
    Hotta, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (02) : 479 - 484
  • [8] DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21WAF1/CIP1/sdi1
    Milutinovic, S
    Knox, JD
    Szyf, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) : 6353 - 6359
  • [9] Relationship of p21WAF1/CIP1/SDI1 to cell proliferation in primary cultures of adrenocortical cells
    James R. Tunstead
    Peter J. Hornsby
    [J]. AGE, 1999, 22
  • [10] Oxygen sensing by primary cardiac fibroblasts -: A key role of p21Waf1/Cip1/Sdi1
    Roy, S
    Khanna, S
    Bickerstaff, AA
    Subramanian, SV
    Atalay, M
    Bierl, M
    Pendyala, S
    Levy, D
    Sharma, N
    Venojarvi, M
    Strauch, A
    Orosz, CG
    Sen, CK
    [J]. CIRCULATION RESEARCH, 2003, 92 (03) : 264 - 271